Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahasweta Gooptu

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Blood Advances|September 28, 2021
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitutionKatie Maurer, Haesook T Kim, Thomas M Kuczmarski, et al.
Transplantation and Cellular Therapy|May 8, 2022
Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release SyndromeJessica S Little, Roman M Shapiro, Muneerah M Aleissa, et al.
Transplantation and Cellular Therapy|April 12, 2021
Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationEvan C Chen, Shuli Li, Ann-Kathrin Eisfeld, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2018
Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled TrialMahasweta Gooptu, Haesook T Kim, Yi-Bin Chen, et al.
Transplantation and Cellular Therapy|April 4, 2023
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationJuliana Vergara-Cadavid, P Connor Johnson, Haesook T Kim, et al.
Blood Advances|May 15, 2024
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survivalRoman M Shapiro, Haesook T Kim, Remy Dulery, et al.
Blood Advances|July 14, 2026
Infection Burden in Mismatched Unrelated Donor Hematopoietic Cell Transplantation: Results from the ACCESS TrialJeffery J Auletta, Joseph Stanek, Stephanie Bo-Subait, et al.
Blood Advances|May 7, 2020
BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantationEduardo Espada, Matthew P Cheng, Haesook T Kim, et al.
Blood Advances|October 6, 2025
Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamideDipenkumar Modi, Yosra M Aljawai, Todd E DeFor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2024
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated DonorsBrian C Shaffer, Mahasweta Gooptu, Todd E DeFor, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Blood Advances|September 28, 2021
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitutionKatie Maurer, Haesook T Kim, Thomas M Kuczmarski, et al.
Transplantation and Cellular Therapy|May 8, 2022
Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release SyndromeJessica S Little, Roman M Shapiro, Muneerah M Aleissa, et al.
Transplantation and Cellular Therapy|April 12, 2021
Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationEvan C Chen, Shuli Li, Ann-Kathrin Eisfeld, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2018
Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled TrialMahasweta Gooptu, Haesook T Kim, Yi-Bin Chen, et al.
Transplantation and Cellular Therapy|April 4, 2023
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationJuliana Vergara-Cadavid, P Connor Johnson, Haesook T Kim, et al.
Blood Advances|May 15, 2024
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survivalRoman M Shapiro, Haesook T Kim, Remy Dulery, et al.
Blood Advances|July 14, 2026
Infection Burden in Mismatched Unrelated Donor Hematopoietic Cell Transplantation: Results from the ACCESS TrialJeffery J Auletta, Joseph Stanek, Stephanie Bo-Subait, et al.
Blood Advances|May 7, 2020
BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantationEduardo Espada, Matthew P Cheng, Haesook T Kim, et al.
Blood Advances|October 6, 2025
Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamideDipenkumar Modi, Yosra M Aljawai, Todd E DeFor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2024
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated DonorsBrian C Shaffer, Mahasweta Gooptu, Todd E DeFor, et al.
Pageof 7